Literature DB >> 17652503

Outcome measures for development of new therapies in cystic fibrosis: are we making progress and what are the next steps?

Bonnie W Ramsey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17652503      PMCID： PMC2647601          DOI： 10.1513/pats.200703-038BR

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN： 1546-3222


× No keyword cloud information.
  30 in total

1.  Defining a pulmonary exacerbation in cystic fibrosis.

Authors:  M Rosenfeld; J Emerson; J Williams-Warren; M Pepe; A Smith; A B Montgomery; B Ramsey
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

2.  Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!

Authors:  Bruce C Marshall
Journal:  Am J Respir Crit Care Med       Date:  2004-04-01       Impact factor: 21.405

Review 3.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

4.  Identifying treatments that halt progression of pulmonary disease in cystic fibrosis.

Authors:  P B Davis; P J Byard; M W Konstan
Journal:  Pediatr Res       Date:  1997-02       Impact factor: 3.756

Review 5.  Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference.

Authors:  B W Ramsey; T F Boat
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

6.  Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements.

Authors:  Pim A de Jong; Mark D Ottink; Simon G F Robben; Maarten H Lequin; Wim C J Hop; Johan J E Hendriks; Peter D Paré; Harm A W M Tiddens
Journal:  Radiology       Date:  2004-04-02       Impact factor: 11.105

7.  Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Authors:  H J Fuchs; D S Borowitz; D H Christiansen; E M Morris; M L Nash; B W Ramsey; B J Rosenstein; A L Smith; M E Wohl
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

8.  Pulmonary exacerbations in cystic fibrosis.

Authors:  Harvey R Rabin; Steven M Butler; Mary Ellen B Wohl; David E Geller; Andrew A Colin; Daniel V Schidlow; Charles A Johnson; Michael W Konstan; Warren E Regelmann
Journal:  Pediatr Pulmonol       Date:  2004-05

9.  Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

Authors:  Michael Wilschanski; Yaacov Yahav; Yasmin Yaacov; Hannah Blau; Lea Bentur; Joseph Rivlin; Micha Aviram; Tali Bdolah-Abram; Zsuzsa Bebok; Liat Shushi; Batsheva Kerem; Eitan Kerem
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

10.  Microbiology of sputum from patients at cystic fibrosis centers in the United States.

Authors:  J L Burns; J Emerson; J R Stapp; D L Yim; J Krzewinski; L Louden; B W Ramsey; C R Clausen
Journal:  Clin Infect Dis       Date:  1998-07       Impact factor: 9.079
View more
  6 in total

Review 1.  Update in cystic fibrosis 2007.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2008-05-15       Impact factor: 21.405

Review 2.  Pediatric hospital medicine and children with medical complexity: past, present, and future.

Authors:  Tamara D Simon; Sanjay Mahant; Eyal Cohen
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2012-05

Review 3.  Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy.

Authors:  Edith T Zemanick; J Kirk Harris; Steven Conway; Michael W Konstan; Bruce Marshall; Alexandra L Quittner; George Retsch-Bogart; Lisa Saiman; Frank J Accurso
Journal:  J Cyst Fibros       Date:  2009-10-14       Impact factor: 5.482

4.  Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

Authors:  Steven M Rowe; Patricia L Jackson; Gang Liu; Mathew Hardison; Alessandra Livraghi; G Martin Solomon; D Brent McQuaid; Brett D Noerager; Amit Gaggar; J P Clancy; Wanda O'Neal; Eric J Sorscher; Edward Abraham; J Edwin Blalock
Journal:  Am J Respir Crit Care Med       Date:  2008-07-24       Impact factor: 21.405

5.  Protein biomarkers in cystic fibrosis research: where next?

Authors:  Sally H Pattison; J Stuart Elborn
Journal:  Genome Med       Date:  2010-12-16       Impact factor: 11.117

6.  In vivo readout of CFTR function: ratiometric measurement of CFTR-dependent secretion by individual, identifiable human sweat glands.

Authors:  Jeffrey J Wine; Jessica E Char; Jonathan Chen; Hyung-Ju Cho; Colleen Dunn; Eric Frisbee; Nam Soo Joo; Carlos Milla; Sara E Modlin; Il-Ho Park; Ewart A C Thomas; Kim V Tran; Rohan Verma; Marlene H Wolfe
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.